Susquehanna International Group
FBIO icon

Susquehanna International Group’s Fortress Biotech FBIO Stock Holding History

Susquehanna International Group’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.09M Buy
356,000
+71,700
+25% +$185K ﹤0.01% 7984
2026
Q1 		$793K Buy
284,300
+61,500
+28% +$209K ﹤0.01% 8497
2025
Q4 		$815K Buy
222,800
+148,500
+200% +$423K ﹤0.01% 7631
2025
Q3 		$275K Buy
74,300
+33,400
+82% +$84.4K ﹤0.01% 10312
2025
Q2 		$76.1K Buy
40,900
+19,600
+92% +$33.9K ﹤0.01% 11935
2025
Q1 		$33.2K Buy
+21,300
New +$37.5K ﹤0.01% 11982
2024
Q4 		– Sell
-12,800
Closed -$18.6K – 12484
2024
Q3 		$18.6K Sell
12,800
-12,200
-49% -$23.2K ﹤0.01% 11641
2024
Q2 		$42.8K Buy
25,000
+15,000
+150% +$27.2K ﹤0.01% 11473
2024
Q1 		$20K Sell
10,000
-6,300
-39% -$12.5K ﹤0.01% 11818
2023
Q4 		$49.1K Buy
+16,300
New +$43.1K ﹤0.01% 11723
2022
Q2 		– Sell
-4,707
Closed -$96K – 13185
2022
Q1 		$96K Sell
4,707
-3,473
-42% -$95.1K ﹤0.01% 11942
2021
Q4 		$307K Buy
8,180
+2,867
+54% +$128K ﹤0.01% 10449
2021
Q3 		$257K Buy
5,313
+1,646
+45% +$80.3K ﹤0.01% 10952
2021
Q2 		$196K Buy
+3,667
New +$221K ﹤0.01% 11623
2019
Q2 		– Sell
-827
Closed -$22K – 10365
2019
Q1 		$22K Buy
+827
New +$21.7K ﹤0.01% 8581
2016
Q4 		– Sell
-3,247
Closed -$145K – 9724
2016
Q3 		$145K Buy
+3,247
New +$138K ﹤0.01% 7790
2015
Q3 		– Sell
-887
Closed -$45K – 9738
2015
Q2 		$45K Sell
887
-946
-52% -$48.5K ﹤0.01% 9896
2015
Q1 		$106K Sell
1,833
-3,667
-67% -$153K ﹤0.01% 8945
2014
Q4 		$201K Buy
5,500
+4,347
+377% +$128K ﹤0.01% 8807
2014
Q3 		$36K Sell
1,153
-1,760
-60% -$46.7K ﹤0.01% 9273
2014
Q2 		$75K Sell
2,913
-87
-3% -$2.29K ﹤0.01% 9513
2014
Q1 		$89K Sell
3,000
-3,027
-50% -$118K ﹤0.01% 8595
2013
Q4 		$238K Sell
6,027
-6,820
-53% -$263K ﹤0.01% 7978
2013
Q3 		$1.35M Buy
12,847
+9,980
+348% +$1.22M ﹤0.01% 4787
2013
Q2 		$370K Buy
+2,867
New +$423K ﹤0.01% 6483

Other funds holding FBIO

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Susquehanna International Group's FBIO Position: Q2 2026 in Review

Susquehanna International Group reduced its Fortress Biotech (FBIO) stake by 78% in Q2 2026, selling an estimated $422K and leaving 47,002 shares worth $144K. The position accounts for ﹤0.01% of the portfolio, ranked #12241.

Susquehanna International Group first reported a position in FBIO in Q2 2013 and has held it in 32 quarters since. The position peaked at $1.32M in Q3 2025. 55 funds tracked by Wall St. Rank hold FBIO as of Q2 2026.

  • Susquehanna International Group held 47,002 shares of Fortress Biotech worth $144K as of Q2 2026.
  • Susquehanna International Group sold 163,743 Fortress Biotech shares in Q2 2026, an estimated $422K.
  • Fortress Biotech made up ﹤0.01% of Susquehanna International Group's portfolio in Q2 2026, its #12241 holding.
  • Susquehanna International Group first reported a position in Fortress Biotech in Q2 2013 and has held it in 32 quarters since.
  • Susquehanna International Group's Fortress Biotech position peaked at $1.32M in Q3 2025.
  • 55 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.